JFG
DNA icon

Jefferies Financial Group’s Ginkgo Bioworks DNA Stock Holding History

Jefferies Financial Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,313
Closed -$154K – 1514
2024
Q1 		$154K Buy
+3,313
New +$171K ﹤0.01% 1381
2023
Q1 		– Sell
-575
Closed -$38.9K – 1707
2022
Q4 		$38.9K Buy
+575
New +$52.9K ﹤0.01% 1424

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Jefferies Financial Group's DNA Position: Q2 2024 in Review

Jefferies Financial Group sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 3,313 shares — an estimated $154K sold.

Jefferies Financial Group first reported a position in DNA in Q4 2022 and held it in 2 quarters. The position peaked at $154K in Q1 2024. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

  • Jefferies Financial Group reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
  • Jefferies Financial Group sold 3,313 Ginkgo Bioworks shares in Q2 2024, an estimated $154K.
  • Jefferies Financial Group first reported a position in Ginkgo Bioworks in Q4 2022 and held it in 2 quarters.
  • Jefferies Financial Group's Ginkgo Bioworks position peaked at $154K in Q1 2024.
  • 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.